What is the ICD‑10‑CM code for progesterone therapy (hormone replacement therapy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10-CM Code for Progesterone Hormone Replacement Therapy

The ICD-10-CM code for progesterone hormone replacement therapy is Z79.890 (Hormone replacement therapy [postmenopausal]).

Primary Coding

  • Z79.890 is the appropriate code for patients receiving hormone replacement therapy, including progesterone as part of postmenopausal HRT regimens 1
  • This code applies whether progesterone is used alone or in combination with estrogen for endometrial protection 1

Additional Relevant Codes

  • Z78.0 may be used as a secondary code if documenting asymptomatic menopausal state 2
  • E28.310 should be used if the indication is premature ovarian insufficiency (POI), as this represents the underlying diagnosis requiring HRT 2, 1
  • N95.1 can be used for menopausal and female climacteric states if vasomotor symptoms are the primary indication 2

Clinical Context for Coding

  • The code Z79.890 is used for long-term (current) hormone replacement therapy, not for short-term or acute prescriptions 1
  • When progesterone is prescribed for contraception rather than HRT, use Z30.41 (Encounter for surveillance of contraceptive pills) instead 2
  • For women with premature ovarian insufficiency requiring HRT until age 45-55 years, both E28.310 and Z79.890 should be documented 2, 1

Documentation Requirements

  • Medical records should specify the type of progesterone (micronized progesterone, medroxyprogesterone acetate, or dydrogesterone) and whether it is sequential (12-14 days/month) or continuous daily dosing 1
  • Document whether the patient has an intact uterus, as this justifies the medical necessity of progesterone for endometrial protection when combined with estrogen 1
  • Annual clinical reviews should be documented with reassessment of risks versus benefits to support ongoing medical necessity 1, 3

References

Guideline

Lowest Dose of Progesterone for Hormone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hormone Replacement Therapy Regimens for Postmenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.